subscribeSubscribe
EC revokes all centrally granted generic marketing permissions for DMF

EC revokes all centrally granted generic marketing permissions for DMF
PR NEWSWIRE
20 Dec 2023
Share Share
Biogen notches another Tecfidera patent win in Europe

Biogen notches another Tecfidera patent win in Europe
Fraiser Kansteiner FIERCE PHARMA
20 Dec 2023
Share Share
Biogen finally scores win in its fight to prevent copycats of MS drug in the EU

Biogen finally scores win in its fight to prevent copycats of MS drug in the EU
Katherine Lewin ENDPTS
04 May 2023
Share Share
Biogen Receives Favorable Decision from Court of the EU Relating to TECFIDERA

Biogen Receives Favorable Decision from Court of the EU Relating to TECFIDERA
PRESS RELEASE
17 Mar 2023
Share Share
Aurobindo`s Generic Dimethyl Fumarate Receives Approval in the U.S.

Aurobindo`s Generic Dimethyl Fumarate Receives Approval in the U.S.
FDA
22 Dec 2022
Share Share
Stem cell transplants may slow disability progression in MS

Stem cell transplants may slow disability progression in MS
Caroline Peachey EUROPEANPHARMACEUTICALREVIEW
22 Dec 2022
Share Share
Prinston`s Generic Dimethyl Fumarate Receives Approval in the U.S.

Prinston`s Generic Dimethyl Fumarate Receives Approval in the U.S.
FDA
18 Oct 2022
Share Share
Biogen`s push to regain Tecfidera patent swatted down by SCOTUS

Biogen`s push to regain Tecfidera patent swatted down by SCOTUS
FIERCEPHARMA
03 Oct 2022
Share Share
Biogen pays $900M to resolve whistleblower`s kickbacks suit

Biogen pays $900M to resolve whistleblower`s kickbacks suit
Angus Liu FIERCEPHARMA
21 Jul 2022
Share Share
Biogen has gained a prominent ally in its Tecfidera patent suit

Biogen has gained a prominent ally in its Tecfidera patent suit
Fraiser Kansteiner FIERCEPHARMA
14 Jul 2022
Share Share